Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1/2 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Gynecologic 4Genitourinary 3Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Dermatologic 1CNS 1Breast 1

Conditions

Rectal Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Liver Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × irofulven × Gastrointestinal × Clear all
NCT00374660 2021-12-08

Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

Eisai Inc.

Phase 1/2 Completed
63 enrolled
Gastrointestinal

Liver Neoplasms

NCT00003441 2018-10-25

Irofulven in Treating Patients With Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase 2 Completed
26 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003786 2014-03-07

Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer

University of Chicago

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00062257 2013-05-15

Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gastrointestinal

Stomach Neoplasms

NCT00033735 2012-12-24

Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer

Eisai Inc.

Phase 3 Completed
158 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00003760 2012-08-09

Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer

The University of Texas Health Science Center at San Antonio

Phase 2 Completed
3 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡